Product Name: GRP170
Product Number: AB-NN265-2
Size: 25 µg      Price:89.00
      $US
Target Full Name: Hypoxia up-regulated protein 1

Target Alias: ORP150; HSP12A; Orp150; Glucose-regulated 170; 150kDa oxygen regulated

Product Type Specific: Heat shock/stress protein pan-specific antibody

Antibody Code: NN265-2

Antibody Target Type: Pan-specific

Protein UniProt: Q9Y4L1

Protein SigNET: Q9Y4L1

Antibody Type: Monoclonal

Antibody Host Species: Mouse

Antibody Ig Isotype Clone: IgG2a

Antibody Immunogen Source: Raised against a synthetic peptide of human GRP170

Production Method: Protein G purified

Antibody Modification: Unconjugated. Contact KInexus if you are interest in having the antibody biotinylated or coupled with fluorescent dyes.

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH7.4, 50% glycerol, 0.1% sodium azide

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting

Antibody Dilution Recommended: WB (1:1000); optimal dilutions for assays should be determined by the user.

Antibody Potency: In mouse brain lysates, this antibody detects a ~170 kDa protein by Western blotting.
Antibody Species Reactivity: Human

Antibody Positive Control: 1 µg/ml of SMC-233 was sufficient for detection of GRP170 in 20 µg of HEK293 lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody.

Antibody Specificity: Very high

Related Product 1: GRP170 pan-specific antibody (Cat. No.: AB-NN265-1)

Scientific Background: GRP170, also known as ORP150, is the largest member of glucose-regulated Antibodys, and acts as a human chaperone Antibody. It is thought to play an important role in Antibody folding and secretion in the ER. Suppression of the Antibody is associated with accelerated apoptosis, therefore having an important cryoprotective role in hypoxia-induced cellular pertubation. This cryopotective role has led to an anti-tumor immune response, which will hopefully lead to therapeutic immunizations against cancers (1). GRP170 has also been shown to bind with dendritic cells and provide the danger signals to induce anti-tumor immune responses (2).